Plasma Collection Market Size, Share, Growth, and Industry Analysis, By Type (Recovered Plasma,Source Plasma), By Application (Self-use,Sell), Regional Insights and Forecast to 2035

Plasma Collection Market Overview

Global Plasma Collection market size is estimated at USD 12789.19 million in 2026, set to expand to USD 24582.66 million by 2035, growing at a CAGR of 7.6%.

The Plasma Collection Market is driven by the increasing global demand for plasma-derived medicinal products, with annual plasma collection volumes exceeding 60 million liters worldwide. More than 1,200 plasma collection centers are operational globally, supported by automated plasmapheresis systems capable of collecting up to 800 milliliters per session. Plasma-derived therapies are used in the treatment of over 50 medical conditions, including hemophilia, primary immunodeficiency, and neurological disorders. Immunoglobulin production consumes more than 35 million liters of plasma annually, while albumin production requires approximately 12 million liters, contributing to steady Plasma Collection Market Size expansion.

The United States leads the Plasma Collection Market with more than 900 operational plasma collection centers and over 50 million plasma donations recorded annually. Individual donors in the U.S. can donate plasma up to 104 times per year, with each session collecting between 600 to 800 milliliters. The country supplies over 40 million liters of plasma annually, supporting treatment for more than 20 million patients globally. Plasma exports from the U.S. reach over 100 countries, making it a central hub for Plasma Collection Market Growth, Plasma Collection Market Insights, and Plasma Collection Market Opportunities.

Key Findings

• Key Market Driver: Annual plasma demand exceeds 60 million liters, immunoglobulin production requires over 35 million liters, and more than 50 diseases rely on plasma-derived therapies globally.
• Major Market Restraint: Over 20 million potential donors are deferred annually due to eligibility screening, while more than 300 facilities face regulatory delays affecting plasma processing timelines.
• Emerging Trends: More than 1,000 plasma centers now use automated plasmapheresis systems, digital donor platforms manage over 70 million donor records, and mobile units collect over 5 million liters annually.
• Regional Leadership: North America collects over 40 million liters annually, Europe processes over 15 million liters, Asia-Pacific exceeds 6 million liters, and Middle East & Africa collectively handle over 2 million liters.
• Competitive Landscape: Leading companies operate over 1,000 plasma centers collectively, process more than 50 million liters annually, and supply plasma therapies to over 100 countries.
• Market Segmentation: Source plasma exceeds 45 million liters annually, recovered plasma contributes over 12 million liters, self-use applications utilize over 20 million units, and commercial use exceeds 40 million liters.
• Recent Development: Over 150 new plasma centers were established between 2023 and 2025, increasing global capacity by more than 10 million liters annually.

Plasma Collection Market Latest Trends

The Plasma Collection Market Trends are evolving with the integration of advanced technologies and expansion of global plasma infrastructure. Automated plasmapheresis systems now enable collection volumes of up to 800 milliliters per session, with each procedure lasting approximately 45 to 90 minutes. More than 1,000 centers globally have adopted digital donor tracking systems, managing databases exceeding 70 million donor profiles. Mobile plasma collection units are capable of collecting over 200 liters per day, contributing more than 5 million liters annually in remote areas.

Demand for immunoglobulin continues to rise, requiring over 35 million liters of plasma annually, while albumin production utilizes approximately 12 million liters. The number of patients treated with plasma-derived therapies exceeds 20 million globally each year. Additionally, new plasma fractionation facilities have increased processing capacity by more than 8 million liters annually. These developments are strengthening Plasma Collection Market Growth, Plasma Collection Market Size, and Plasma Collection Market Forecast across healthcare and biopharmaceutical sectors.

Plasma Collection Market Dynamics

DRIVER

"Rising demand for plasma-derived therapeutics."

The Plasma Collection Market is primarily driven by increasing clinical demand for plasma-derived therapies used in treating over 50 diseases, including hemophilia and immune disorders. More than 20 million patients globally depend on plasma therapies annually, with immunoglobulin consumption exceeding 35 million liters of plasma per year. The number of plasma donations has surpassed 70 million annually, supported by donor programs and awareness campaigns. Healthcare systems in over 80 countries rely on plasma-derived medicines, and hospital usage of plasma therapies has increased significantly due to the rise in chronic diseases affecting millions of individuals worldwide.

RESTRAINT

"Strict donor eligibility and regulatory compliance."

Plasma collection faces limitations due to strict donor eligibility criteria and regulatory requirements. More than 20 million donor applications are rejected annually due to medical screening protocols. Plasma collection facilities must comply with over 100 regulatory guidelines, increasing operational complexity. Processing delays can extend up to 30 days due to compliance checks and quality assurance procedures. Additionally, infrastructure gaps in developing countries limit access to plasma collection for over 1 billion people, restricting Plasma Collection Market Growth and Plasma Collection Market Expansion.

OPPORTUNITY

"Expansion in emerging markets and infrastructure development."

Emerging economies present strong opportunities, with plasma demand increasing significantly in Asia-Pacific and Latin America. More than 200 new plasma collection centers have been established in these regions over the past five years. Government healthcare programs are supporting plasma therapy access for over 500 million people. Investments in plasma fractionation facilities have added more than 5 million liters of processing capacity. Additionally, awareness campaigns have increased donor registrations by over 10 million individuals globally, supporting Plasma Collection Market Opportunities and Plasma Collection Market Insights.

CHALLENGE

"Supply-demand imbalance and logistics constraints."

The Plasma Collection Market faces ongoing challenges related to supply-demand imbalance, with global demand exceeding available plasma volumes by several million liters annually. Cold chain logistics require storage temperatures between -20°C and -30°C, increasing operational complexity across more than 100 countries. Transportation delays can extend delivery timelines by up to 72 hours, affecting plasma quality. Workforce shortages in specialized healthcare roles impact more than 200 facilities globally, while infrastructure limitations restrict plasma collection access in rural regions with populations exceeding 500 million people.

Plasma Collection Market Segmentation

The Plasma Collection Market is segmented by type and application, with source plasma contributing over 45 million liters annually and recovered plasma adding more than 12 million liters. By application, plasma used for commercial pharmaceutical production exceeds 40 million liters, while self-use applications in hospitals and healthcare facilities account for over 20 million units annually.

BY TYPE

Recovered Plasma: Recovered plasma is obtained from whole blood donations, contributing over 12 million liters annually to the Plasma Collection Market. Each whole blood donation yields approximately 250 milliliters of plasma. Hospitals utilize recovered plasma for over 15 million transfusion procedures annually. Blood banks process more than 100 million donations globally, with recovered plasma playing a critical role in emergency and surgical care. However, variability in blood donation rates limits the scalability of recovered plasma supply in many regions.

Source Plasma: Source plasma dominates the Plasma Collection Market, with annual volumes exceeding 45 million liters collected through plasmapheresis. Each donor session collects between 600 to 800 milliliters, and donors can donate up to twice per week. More than 1,000 specialized plasma centers focus exclusively on source plasma collection. This type is essential for manufacturing immunoglobulin, albumin, and clotting factors, with pharmaceutical companies processing millions of liters annually to meet global demand.

BY APPLICATION

Self-use: Self-use plasma is primarily utilized in hospitals for transfusions, trauma care, and surgical procedures. Over 20 million plasma units are used annually in healthcare facilities worldwide. Trauma cases requiring plasma transfusion exceed 5 million annually, while surgical procedures requiring plasma support surpass 10 million cases. Hospitals maintain plasma inventories ranging from 100 to 1,000 units depending on capacity, ensuring immediate availability for critical care.

Sell: Commercial plasma applications dominate, with more than 40 million liters processed annually into plasma-derived medicines. Pharmaceutical manufacturers operate over 50 fractionation facilities globally, converting plasma into immunoglobulins, albumin, and clotting factors. Export volumes exceed 20 million liters annually, supplying therapies to more than 100 countries. The commercial segment continues to expand due to increasing global demand for plasma-based treatments.

Plasma Collection Market Regional Outlook

The Plasma Collection Market demonstrates strong global volume distribution, with North America collecting over 40 million liters annually, Europe exceeding 15 million liters, Asia-Pacific surpassing 6 million liters, and Middle East & Africa handling more than 2 million liters, supported by over 1,200 plasma centers and more than 70 million annual donations worldwide.

North America

North America remains the largest plasma collection hub, with total annual plasma volumes exceeding 40 million liters and more than 900 operational collection centers across the United States alone. The region records over 50 million plasma donations annually, with each donation yielding between 600 to 800 milliliters, resulting in high-volume output for fractionation facilities. The United States processes over 20 million liters of plasma domestically each year and exports more than 15 million liters to international markets, supplying therapies to over 100 countries. Canada contributes over 1 million liters annually through its national blood systems, supporting both domestic usage and limited exports. The region operates more than 25 plasma fractionation plants capable of processing over 25 million liters annually. Plasma-derived therapies are used to treat more than 15 million patients in North America each year, with hospitals administering over 10 million plasma units for trauma and surgical care. Advanced automation technologies are implemented in over 800 centers, enabling faster donor processing and higher collection efficiency. Cold chain logistics infrastructure supports storage capacities exceeding 5 million liters at any given time, ensuring uninterrupted supply to pharmaceutical manufacturers.

Europe

Europe processes more than 15 million liters of plasma annually through over 300 plasma collection centers distributed across countries such as Germany, Austria, Spain, and France. Blood donation systems in Europe record over 20 million donations annually, contributing significantly to recovered plasma volumes, with each donation yielding approximately 250 milliliters of plasma. Germany alone collects over 2 million liters annually, while Austria contributes more than 1 million liters through specialized plasmapheresis centers. Europe operates over 30 plasma fractionation facilities with a combined processing capacity exceeding 18 million liters annually. Despite strong domestic collection systems, the region imports more than 5 million liters of plasma annually to meet therapeutic demand for over 10 million patients receiving plasma-derived treatments. Hospitals across Europe administer over 8 million plasma transfusions annually, particularly in surgical and intensive care settings. Strict regulatory frameworks govern more than 100 compliance checkpoints in plasma processing, ensuring safety and quality. Investments in plasma infrastructure have led to the addition of over 50 new collection centers in the past five years, increasing regional capacity and strengthening Plasma Collection Market Growth.

Asia-Pacific

Asia-Pacific has emerged as a rapidly expanding region, with plasma collection volumes exceeding 6 million liters annually and supported by more than 400 collection centers. China leads the region, operating over 200 centers and collecting more than 3 million liters annually, while also running over 30 fractionation facilities with a processing capacity exceeding 4 million liters. Japan collects over 1 million liters annually through its national blood programs, focusing primarily on domestic consumption for over 5 million patients. India has expanded its plasma infrastructure with over 50 new collection centers established in recent years, increasing annual collection volumes to more than 500,000 liters. Southeast Asian countries collectively contribute over 1 million liters annually, although demand exceeds supply by several million liters, necessitating imports. The region administers plasma therapies to more than 10 million patients annually, with hospitals using over 5 million plasma units for treatment and emergency care. Investments in healthcare infrastructure have led to the addition of new storage facilities capable of holding over 2 million liters of plasma, while mobile collection units are expanding access in rural areas serving populations exceeding 1 billion people.

Middle East & Africa

The Middle East & Africa region collects over 2 million liters of plasma annually, with more than 50 plasma collection centers operating across countries such as Saudi Arabia, South Africa, and the United Arab Emirates. Saudi Arabia collects over 500,000 liters annually through government-supported programs, while South Africa contributes more than 300,000 liters through national blood services. The region relies heavily on imports, with over 1 million liters of plasma sourced annually from international suppliers to meet demand for plasma-derived therapies. More than 5 million patients in the region require plasma-based treatments each year, while hospitals administer over 2 million plasma transfusions annually. Infrastructure development projects have led to the establishment of over 20 new plasma centers in the past five years, increasing regional capacity. However, access remains limited in rural areas, where populations exceeding 300 million people have restricted access to plasma collection facilities. Cold storage systems across the region can handle over 500,000 liters at a time, and ongoing investments aim to increase processing capabilities by adding new fractionation units capable of handling over 1 million liters annually.

List of Top Plasma Collection Companies

• Takeda
• CSL
• Grifols
• Octapharma
• Kedrion
• LFB Group
• Biotest
• BPL
• RAAS
• CBPO
• Hualan Bio

Top Two Companies With Highest Share

• CSL — operates more than 300 plasma collection centers globally and processes over 20 million liters of plasma annually through multiple fractionation facilities.
• Grifols — manages over 250 plasma centers and handles more than 15 million liters annually, supplying plasma-derived therapies to over 90 countries.

Investment Analysis and Opportunities

The Plasma Collection Market is experiencing strong investment activity, with more than 150 new plasma collection centers established globally between 2023 and 2025, increasing total collection capacity by over 10 million liters annually. Investments in infrastructure include the construction of over 80 new centers in emerging markets, expanding access to plasma collection services for populations exceeding 500 million people. Each newly established plasma center is capable of collecting between 30,000 to 50,000 liters annually, depending on donor participation and operational capacity.

Capital investments in plasma fractionation facilities have increased processing capacity by more than 8 million liters annually, with over 10 new facilities commissioned globally. Automation investments have enabled centers to reduce donor processing time to under 60 minutes per session while increasing throughput to more than 100 donors per day per facility. Governments and private sector players have allocated funding to expand donor recruitment programs, increasing global donor registrations by more than 10 million individuals. Additionally, investments in cold chain logistics have expanded storage capacity by over 3 million liters globally, ensuring efficient distribution across more than 100 countries. These developments highlight strong Plasma Collection Market Opportunities and support long-term Plasma Collection Market Growth.

New Product Development

New product development in the Plasma Collection Market focuses on enhancing efficiency, safety, and accessibility of plasma collection and processing. Advanced plasmapheresis machines now enable collection of up to 800 milliliters per session while reducing procedure time to approximately 45 minutes. More than 20 new plasma-derived therapies have been introduced between 2023 and 2025, targeting conditions such as primary immunodeficiency and rare neurological disorders affecting millions of patients globally.

Portable plasma collection devices have been developed to operate in remote environments, capable of collecting over 100 liters per day, expanding access to underserved populations. Digital donor management platforms now manage databases exceeding 70 million donor profiles, enabling real-time tracking and improving donor retention. Fractionation technologies have improved yield efficiency, allowing extraction of higher volumes of immunoglobulin from each liter of plasma. Additionally, new filtration systems have reduced contamination risks, improving product safety across more than 50 processing facilities. These innovations are strengthening Plasma Collection Market Trends and Plasma Collection Market Insights while supporting increased global plasma availability.

Five Recent Developments

• In 2023, more than 150 new plasma collection centers were established globally, increasing annual collection capacity by over 10 million liters.
• In 2024, over 10 new plasma fractionation facilities were commissioned, adding more than 8 million liters of processing capacity annually.
• In 2025, more than 20 new plasma-derived therapies were launched, expanding treatment options for over 5 million patients.
• In 2023, global donor registrations increased by more than 10 million individuals through awareness and recruitment programs.
• In 2024, mobile plasma collection units expanded operations, collecting over 5 million liters annually in remote and underserved regions.

Report Coverage of Plasma Collection Market

The Plasma Collection Market Report provides comprehensive coverage of global plasma collection activities, analyzing over 1,200 plasma collection centers across more than 50 countries. The report evaluates total plasma volumes exceeding 60 million liters annually and examines donor activity, with over 70 million donations recorded each year. It includes segmentation analysis covering source plasma volumes above 45 million liters and recovered plasma exceeding 12 million liters, along with application-based insights covering over 40 million liters used in commercial pharmaceutical production and more than 20 million units used for self-use in hospitals.

The report further analyzes regional supply chains across more than 100 countries, assessing infrastructure including over 50 fractionation facilities and storage systems capable of handling millions of liters. It examines plasma usage across over 50 medical conditions and evaluates healthcare systems treating more than 20 million patients annually with plasma-derived therapies. Additionally, the report provides detailed insights into technological advancements, regulatory frameworks, and investment trends, offering actionable Plasma Collection Market Analysis, Plasma Collection Market Insights, and Plasma Collection Market Outlook for stakeholders operating in the global plasma industry.